Signaling pathways influencing tumor microenvironment and their exploitation for targeted drug delivery
暂无分享,去创建一个
Gregory Franklin | C. Sheeba | Gregory Marslin | Ann Mary Revina | G. Franklin | Caroline J. Sheeba | Gregory Marslin
[1] W. Rutter,et al. Expression and characterization of a functional human insulin-like growth factor I receptor. , 1988, The Journal of biological chemistry.
[2] Amit Jain,et al. Development of surface-functionalised nanoparticles for FGF2 receptor-based solid tumour targeting , 2012, Journal of microencapsulation.
[3] R. Roskoski,et al. Vascular endothelial growth factor (VEGF) signaling in tumor progression. , 2007, Critical reviews in oncology/hematology.
[4] L. Strizzi,et al. Rbpj conditional knockout reveals distinct functions of Notch4/Int3 in mammary gland development and tumorigenesis , 2009, Oncogene.
[5] Andrius Kazlauskas,et al. PDGF signaling in cells and mice. , 2004, Cytokine & growth factor reviews.
[6] R. Weinberg,et al. Heterotypic signaling between epithelial tumor cells and fibroblasts in carcinoma formation. , 2001, Experimental cell research.
[7] Erik C. Dreaden,et al. Tamoxifen-poly(ethylene glycol)-thiol gold nanoparticle conjugates: enhanced potency and selective delivery for breast cancer treatment. , 2009, Bioconjugate chemistry.
[8] M. Kazanietz,et al. Hedgehog proteins activate pro-angiogenic responses in endothelial cells through non-canonical signaling pathways , 2010, Cell cycle.
[9] J. Kuemmerle. IGF-I elicits growth of human intestinal smooth muscle cells by activation of PI3K, PDK-1, and p70S6 kinase. , 2003, American journal of physiology. Gastrointestinal and liver physiology.
[10] Patrick Maisonneuve,et al. Loss of negative regulation by Numb over Notch is relevant to human breast carcinogenesis , 2004, The Journal of cell biology.
[11] B. Groner,et al. The Biological Functions of the Versatile Transcription Factors STAT3 and STAT5 and New Strategies for their Targeted Inhibition , 2006, Journal of Mammary Gland Biology and Neoplasia.
[12] U. Rüther,et al. The Shh-independent activator function of the full-length Gli3 protein and its role in vertebrate limb digit patterning. , 2007, Developmental biology.
[13] F. Puglisi,et al. Overcoming Treatment Resistance in HER2-Positive Breast Cancer , 2012, Drugs.
[14] T. Dønnem,et al. Co-expression of PDGF-B and VEGFR-3 strongly correlates with lymph node metastasis and poor survival in non-small-cell lung cancer. , 2010, Annals of oncology : official journal of the European Society for Medical Oncology.
[15] M. Frohman,et al. Targeting phospholipase D with small-molecule inhibitors as a potential therapeutic approach for cancer metastasis. , 2009, Future oncology.
[16] A. Tedesco,et al. Characterization of biodegradable poly(D,L-lactide-co-glycolide) nanoparticles loaded with bacteriochlorophyll-a for photodynamic therapy. , 2007, Photomedicine and laser surgery.
[17] R. Gabathuler,et al. Approaches to transport therapeutic drugs across the blood–brain barrier to treat brain diseases , 2010, Neurobiology of Disease.
[18] H. Antoniades,et al. Expression of platelet‐derived growth factor (PDGF)‐A, PDGF‐B and the PDGF‐alpha receptor, but not the PDGF‐beta receptor, in human malignant melanoma in vivo , 1996, The British journal of dermatology.
[19] J. Romashkova,et al. NF-κB is a target of AKT in anti-apoptotic PDGF signalling , 1999, Nature.
[20] T. Park,et al. Enhanced intracellular delivery of quantum dot and adenovirus nanoparticles triggered by acidic pH via surface charge reversal. , 2008, Bioconjugate chemistry.
[21] P. Rida,et al. A Notch feeling of somite segmentation and beyond. , 2004, Developmental biology.
[22] Cheryl S Watson,et al. Membrane estrogen receptor-α levels in MCF-7 breast cancer cells predict cAMP and proliferation responses , 2004, Breast Cancer Research.
[23] R. Habas,et al. SnapShot: Noncanonical Wnt Signaling Pathways , 2007, Cell.
[24] M. Emi,et al. Amplification, up‐regulation and over‐expression of DVL‐1, the human counterpart of the Drosophila disheveled gene, in primary breast cancers , 2003, Cancer science.
[25] A. Harris,et al. Hypoxia-inducible factor-1 modulates gene expression in solid tumors and influences both angiogenesis and tumor growth. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[26] Liz Y. Han,et al. Functional significance of VEGFR‐2 on ovarian cancer cells , 2009, International journal of cancer.
[27] A. Goate,et al. Aph-2/Nicastrin An Essential Component of γ-Secretase and Regulator of Notch Signaling and Presenilin Localization , 2002, Neuron.
[28] G. Lockwood,et al. High-level coexpression of JAG1 and NOTCH1 is observed in human breast cancer and is associated with poor overall survival. , 2005, Cancer research.
[29] A. Belfiore,et al. Insulin receptor and cancer. , 2011, Endocrine-related cancer.
[30] Yosef Yarden,et al. Signal transduction and oncogenesis by ErbB/HER receptors. , 2004, International journal of radiation oncology, biology, physics.
[31] Charles M Perou,et al. A novel lung metastasis signature links Wnt signaling with cancer cell self-renewal and epithelial-mesenchymal transition in basal-like breast cancer. , 2009, Cancer research.
[32] J. Budczies,et al. Heterogeneous expression of Wnt/β‐catenin target genes within colorectal cancer , 2007, International journal of cancer.
[33] Ji Luo,et al. The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism , 2006, Nature Reviews Genetics.
[34] A. Atfi,et al. Insulin-Mediated Cell Proliferation and Survival Involve Inhibition of c-Jun N-terminal Kinases through a Phosphatidylinositol 3-Kinase- and Mitogen-Activated Protein Kinase Phosphatase-1-Dependent Pathway. , 2000, Endocrinology.
[35] T. Noda,et al. Involvement of Flt-1 tyrosine kinase (vascular endothelial growth factor receptor-1) in pathological angiogenesis. , 2001, Cancer research.
[36] S. Burma,et al. Epidermal growth factor receptor in glioma: signal transduction, neuropathology, imaging, and radioresistance. , 2010, Neoplasia.
[37] G. Hortobagyi,et al. Upregulation of CXCR4 is essential for HER2-mediated tumor metastasis. , 2004, Cancer cell.
[38] W. Engström,et al. Insulin-Like Growth Factor 2 in Development and Disease: A Mini-Review , 2012, Gerontology.
[39] W. Cavenee,et al. Platelet-derived growth factor-B enhances glioma angiogenesis by stimulating vascular endothelial growth factor expression in tumor endothelia and by promoting pericyte recruitment. , 2003, The American journal of pathology.
[40] H. Werner,et al. The insulin-like growth factor-I receptor as an oncogene , 2009, Archives of physiology and biochemistry.
[41] Luzhe Sun,et al. Extranuclear functions of ER impact invasive migration and metastasis by breast cancer cells. , 2010, Cancer research.
[42] P. Pisani. Hyper-insulinaemia and cancer, meta-analyses of epidemiological studies. , 2008, Archives of physiology and biochemistry.
[43] Jayanth Panyam,et al. Rapid endo‐lysosomal escape of poly(DL‐lactide‐coglycolide) nanoparticles: implications for drug and gene delivery , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[44] A. Chott,et al. Platelet-Derived Growth Factor-AA and -α Receptor Expression Suggests an Autocrine and/or Paracrine Loop in Osteosarcoma , 2000, Modern Pathology.
[45] L. Williams,et al. Vascular endothelial growth factor receptor expression during embryogenesis and tissue repair suggests a role in endothelial differentiation and blood vessel growth. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[46] I. Palmeirim,et al. Joint interpretation of AER/FGF and ZPA/SHH over time and space underlies hairy2 expression in the chick limb , 2012, Biology Open.
[47] J. Griffin,et al. Modulation of Notch signaling by mastermind-like (MAML) transcriptional co-activators and their involvement in tumorigenesis. , 2004, Seminars in cancer biology.
[48] D. Min,et al. Positive Feedback Regulation between Phospholipase D and Wnt Signaling Promotes Wnt-Driven Anchorage-Independent Growth of Colorectal Cancer Cells , 2010, PloS one.
[49] Scott R. Presnell,et al. A dual-targeting PDGFRβ/VEGF-A molecule assembled from stable antibody fragments demonstrates anti-angiogenic activity in vitro and in vivo , 2010, mAbs.
[50] G. Viglietto,et al. The MEK/MAPK pathway is involved in the resistance of breast cancer cells to the EGFR tyrosine kinase inhibitor gefitinib , 2006, Journal of cellular physiology.
[51] Barbara Stecca,et al. Context-dependent regulation of the GLI code in cancer by HEDGEHOG and non-HEDGEHOG signals. , 2010, Journal of molecular cell biology.
[52] L. Miele,et al. Cancer stem cells – an old idea that’s new again: implications for the diagnosis and treatment of breast cancer , 2007, Expert opinion on biological therapy.
[53] Laura Sciacca,et al. Insulin receptor isoforms and insulin receptor/insulin-like growth factor receptor hybrids in physiology and disease. , 2009, Endocrine reviews.
[54] Zhiwei Wang,et al. Platelet‐Derived Growth Factor‐D Overexpression Contributes to Epithelial‐Mesenchymal Transition of PC3 Prostate Cancer Cells , 2008, Stem cells.
[55] Xi He,et al. Wnt/beta-catenin signaling: components, mechanisms, and diseases. , 2009, Developmental cell.
[56] Jinho Park,et al. Targeting Strategies for Multifunctional Nanoparticles in Cancer Imaging and Therapy , 2012, Theranostics.
[57] M. V. Lozano,et al. Anti-tumor efficacy of chitosan-g-poly(ethylene glycol) nanocapsules containing docetaxel: anti-TMEFF-2 functionalized nanocapsules vs. non-functionalized nanocapsules. , 2013, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[58] Thomas E Rohan,et al. Insulin, insulin-like growth factor-I, and risk of breast cancer in postmenopausal women. , 2009, Journal of the National Cancer Institute.
[59] Deepa Subramanyam,et al. Cooperation of Notch and Ras/MAPK signaling pathways in human breast carcinogenesis , 2009, Molecular Cancer.
[60] N. Hynes,et al. Differential Roles of Fibroblast Growth Factor Receptors (FGFR) 1, 2 and 3 in the Regulation of S115 Breast Cancer Cell Growth , 2012, PloS one.
[61] Ashok R Venkitaraman,et al. Cancer Susceptibility and the Functions of BRCA1 and BRCA2 , 2002, Cell.
[62] J. Kreuter. Transport of Drugs Across the Blood-Brain Barrier by Nanoparticles , 2002 .
[63] M. Sigvardsson,et al. The Notch-2 Gene Is Regulated by Wnt Signaling in Cultured Colorectal Cancer Cells , 2011, PloS one.
[64] M. Ittmann,et al. Alterations in expression of basic fibroblast growth factor (FGF) 2 and its receptor FGFR-1 in human prostate cancer. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.
[65] F. Oswald,et al. The Notch signaling pathway: Transcriptional regulation at Notch target genes , 2009, Cellular and Molecular Life Sciences.
[66] A. Pandiella,et al. HER3 overexpression and survival in solid tumors: a meta-analysis. , 2013, Journal of the National Cancer Institute.
[67] R. Kageyama,et al. HES-1 preserves purified hematopoietic stem cells ex vivo and accumulates side population cells in vivo. , 2003, Blood.
[68] P. Sánchez,et al. HEDGEHOG-GLI1 Signaling Regulates Human Glioma Growth, Cancer Stem Cell Self-Renewal, and Tumorigenicity , 2007, Current Biology.
[69] A. Maitra,et al. Polymeric Nanoparticle-Encapsulated Hedgehog Pathway Inhibitor HPI-1 (NanoHHI) Inhibits Systemic Metastases in an Orthotopic Model of Human Hepatocellular Carcinoma , 2011, Clinical Cancer Research.
[70] R. Clarke,et al. Mammary Stem Cells and Breast Cancer—Role of Notch Signalling , 2007, Stem Cell Reviews.
[71] G. Christofori,et al. Placental growth factor-1 attenuates vascular endothelial growth factor-A-dependent tumor angiogenesis during beta cell carcinogenesis. , 2007, Cancer research.
[72] B. Hemmings,et al. Identification of a PKB/Akt Hydrophobic Motif Ser-473 Kinase as DNA-dependent Protein Kinase*♦ , 2004, Journal of Biological Chemistry.
[73] Ryoichiro Kageyama,et al. The role of Hes genes in intestinal development, homeostasis and tumor formation , 2012, Development.
[74] A. Karsan,et al. Recent insights into the role of Notch signaling in tumorigenesis. , 2006, Blood.
[75] D. Bar-Sagi,et al. Phospholipase D2-generated phosphatidic acid couples EGFR stimulation to Ras activation by Sos , 2007, Nature Cell Biology.
[76] M. Bernier,et al. Akt-dependent antiapoptotic action of insulin is sensitive to farnesyltransferase inhibitor. , 2000, Biochemistry.
[77] Nancy L Oleinick,et al. EGFR-mediated intracellular delivery of Pc 4 nanoformulation for targeted photodynamic therapy of cancer: in vitro studies. , 2012, Nanomedicine : nanotechnology, biology, and medicine.
[78] N. Sonenberg,et al. Upstream and downstream of mTOR. , 2004, Genes & development.
[79] R. Swann,et al. Vascular Endothelial Growth Factor Receptors VEGFR-2 and VEGFR-3 Are Localized Primarily to the Vasculature in Human Primary Solid Cancers , 2010, Clinical Cancer Research.
[80] J. Pell,et al. Differential regulation of transcription initiation from insulin-like growth factor-I (IGF-I) leader exons and of tissue IGF-I expression in response to changed growth hormone and nutritional status in sheep. , 1993, Endocrinology.
[81] Qiulian Wu,et al. Platelet-derived growth factor receptors differentially inform intertumoral and intratumoral heterogeneity. , 2012, Genes & development.
[82] Zhiwei Wang,et al. RETRACTED ARTICLE: Platelet-derived growth factor-D contributes to aggressiveness of breast cancer cells by up-regulating Notch and NF-κB signaling pathways , 2011, Breast Cancer Research and Treatment.
[83] J. Trevino,et al. c-Src Regulates Constitutive and EGF-mediated VEGF Expression in Pancreatic Tumor Cells Through Activation of Phosphatidyl Inositol-3 Kinase and p38 MAPK , 2005, Pancreas.
[84] D. Rose,et al. The cellular and molecular mechanisms by which insulin influences breast cancer risk and progression. , 2012, Endocrine-related cancer.
[85] S. Barsky,et al. ERα suppresses slug expression directly by transcriptional repression , 2008, The Biochemical journal.
[86] Michael J Yaszemski,et al. Potential therapeutic application of gold nanoparticles in B-chronic lymphocytic leukemia (BCLL): enhancing apoptosis , 2007, Journal of nanobiotechnology.
[87] I. Kasman,et al. PDGF-C mediates the angiogenic and tumorigenic properties of fibroblasts associated with tumors refractory to anti-VEGF treatment. , 2009, Cancer cell.
[88] M. Mimeault,et al. Frequent Deregulations in the Hedgehog Signaling Network and Cross-Talks with the Epidermal Growth Factor Receptor Pathway Involved in Cancer Progression and Targeted Therapies , 2010, Pharmacological Reviews.
[89] Y. Oh,et al. Antitumor activity of EGFR targeted pH-sensitive immunoliposomes encapsulating gemcitabine in A549 xenograft nude mice. , 2009, Journal of controlled release : official journal of the Controlled Release Society.
[90] A. Zmijewska,et al. Physiological and Pathological Changes in Glucose Regulate Brain Akt and Glycogen Synthase Kinase-3* , 2005, Journal of Biological Chemistry.
[91] Notch2 signaling induces apoptosis and inhibits human MDA-MB-231 xenograft growth. , 2007, The American journal of pathology.
[92] J. Bishop,et al. Suppressor of Fused represses Gli-mediated transcription by recruiting the SAP18-mSin3 corepressor complex , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[93] Fang Wang,et al. Multifunctional core-shell upconverting nanoparticles for imaging and photodynamic therapy of liver cancer cells. , 2012, Chemistry, an Asian journal.
[94] S. Frisch,et al. Anoikis mechanisms. , 2001, Current opinion in cell biology.
[95] M. Shibuya,et al. Vascular endothelial growth factor receptor-1 signaling promotes mobilization of macrophage lineage cells from bone marrow and stimulates solid tumor growth. , 2010, Cancer research.
[96] Randall T. Moon,et al. Wnt and calcium signaling: β-Catenin-independent pathways , 2005 .
[97] C. Rudin,et al. A Polymeric Nanoparticle Encapsulated Small-Molecule Inhibitor of Hedgehog Signaling (NanoHHI) Bypasses Secondary Mutational Resistance to Smoothened Antagonists , 2011, Molecular Cancer Therapeutics.
[98] P. Neth,et al. The Wnt Signal Transduction Pathway in Stem Cells and Cancer Cells: Influence on Cellular Invasion , 2007, Stem Cell Reviews.
[99] N. Caplen,et al. Gene Therapy Progress and Prospects. Downregulating gene expression: the impact of RNA interference , 2004, Gene Therapy.
[100] G. Tzivion,et al. FoxO transcription factors; Regulation by AKT and 14-3-3 proteins. , 2011, Biochimica et biophysica acta.
[101] Mauro Ferrari,et al. Nanogeometry: beyond drug delivery. , 2008, Nature nanotechnology.
[102] K. Izumi,et al. Inhibitory effect of soluble platelet‐derived growth factor receptor β on intraosseous growth of breast cancer cells in nude mice , 2011, Cancer science.
[103] W. Berdel,et al. Angiogenesis inhibition in cancer therapy: platelet-derived growth factor (PDGF) and vascular endothelial growth factor (VEGF) and their receptors: biological functions and role in malignancy. , 2010, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.
[104] 上野 耕司. Frizzled-7 as a potential therapeutic target in colorectal cancer , 2009 .
[105] J. Meyerhardt,et al. Insulin, the insulin-like growth factor axis, and mortality in patients with nonmetastatic colorectal cancer. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[106] Guang Liang,et al. Anticancer molecules targeting fibroblast growth factor receptors. , 2012, Trends in pharmacological sciences.
[107] D. A. Russell,et al. Targeted photodynamic therapy of breast cancer cells using antibody-phthalocyanine-gold nanoparticle conjugates , 2011, Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology.
[108] P. Rennie,et al. Lipid nanoparticle siRNA systems for silencing the androgen receptor in human prostate cancer in vivo , 2012, International journal of cancer.
[109] Caicun Zhou,et al. Integrin beta1 over‐expression associates with resistance to tyrosine kinase inhibitor gefitinib in non‐small cell lung cancer , 2010, Journal of cellular biochemistry.
[110] J. Krise,et al. Intracellular drug sequestration events associated with the emergence of multidrug resistance: a mechanistic review. , 2005, Frontiers in bioscience : a journal and virtual library.
[111] Stephen B. Baylin,et al. Hedgehog signalling within airway epithelial progenitors and in small-cell lung cancer , 2003, Nature.
[112] Doaa A. Abdel Fadeel,et al. Zinc phthalocyanine-loaded PLGA biodegradable nanoparticles for photodynamic therapy in tumor-bearing mice , 2010, Lasers in Medical Science.
[113] David J. Yang,et al. Prognostic Effect of Epidermal Growth Factor Receptor and EGFRvIII in Glioblastoma Multiforme Patients , 2005, Clinical Cancer Research.
[114] Edward J Oakeley,et al. WNT signaling enhances breast cancer cell motility and blockade of the WNT pathway by sFRP1 suppresses MDA-MB-231 xenograft growth , 2009, Breast Cancer Research.
[115] R. Boyle,et al. Polyacrylamide nanoparticles as a delivery system in photodynamic therapy. , 2011, Molecular pharmaceutics.
[116] Manuel Arruebo,et al. Antibody-conjugated nanoparticles for biomedical applications , 2009 .
[117] D. Alessi,et al. Role of the PDK1–PKB–GSK3 pathway in regulating glycogen synthase and glucose uptake in the heart , 2005, FEBS letters.
[118] Maria Kasper,et al. Selective Modulation of Hedgehog/GLI Target Gene Expression by Epidermal Growth Factor Signaling in Human Keratinocytes , 2006, Molecular and Cellular Biology.
[119] A. Merchant,et al. Targeting Hedgehog — a Cancer Stem Cell Pathway , 2010, Clinical Cancer Research.
[120] L. Chin,et al. Malignant astrocytic glioma: genetics, biology, and paths to treatment. , 2007, Genes & development.
[121] S. Nair,et al. Cetuximab conjugated O-carboxymethyl chitosan nanoparticles for targeting EGFR overexpressing cancer cells. , 2013, Carbohydrate polymers.
[122] J. Balligand,et al. Hsp90 Ensures the Transition from the Early Ca2+-dependent to the Late Phosphorylation-dependent Activation of the Endothelial Nitric-oxide Synthase in Vascular Endothelial Growth Factor-exposed Endothelial Cells* , 2001, The Journal of Biological Chemistry.
[123] Michael D Schaller,et al. The interplay between Src and integrins in normal and tumor biology , 2004, Oncogene.
[124] J. Kreuter,et al. Drug delivery to the central nervous system by polymeric nanoparticles: what do we know? , 2014, Advanced drug delivery reviews.
[125] M. Moasser,et al. The epidermal growth factor receptor family: Biology driving targeted therapeutics , 2008, Cellular and Molecular Life Sciences.
[126] B. Liu,et al. Nanoparticles modified with tumor-targeting scFv deliver siRNA and miRNA for cancer therapy. , 2010, Molecular therapy : the journal of the American Society of Gene Therapy.
[127] M. Shupnik,et al. Integration of steroid and growth factor pathways in breast cancer: focus on signal transducers and activators of transcription and their potential role in resistance. , 2007, Molecular endocrinology.
[128] Barbara Stecca,et al. Melanomas require HEDGEHOG-GLI signaling regulated by interactions between GLI1 and the RAS-MEK/AKT pathways , 2007, Proceedings of the National Academy of Sciences.
[129] N. Ferrara,et al. The biology of VEGF and its receptors , 2003, Nature Medicine.
[130] A. Capobianco,et al. Induction of Cyclin D1 Transcription and CDK2 Activity by Notchic: Implication for Cell Cycle Disruption in Transformation by Notchic , 2001, Molecular and Cellular Biology.
[131] C. Gicquel,et al. Loss of heterozygosity at the mannose 6-phosphate/insulin-like growth factor 2 receptor locus: a frequent but late event in adrenocortical tumorigenesis. , 2001, European journal of endocrinology.
[132] F. Marshall,et al. The Prostate 69 : 949 ^ 955 ( 2009 ) Soluble FactorsDerived FromStromaActivated AndrogenReceptor Phosphorylation inHuman Prostate LNCaPCells : Roles of ERK / MAPKinase , 2009 .
[133] Sarat Chandarlapaty,et al. AKT inhibition relieves feedback suppression of receptor tyrosine kinase expression and activity. , 2011, Cancer cell.
[134] G. Martin. The hunting of the Src , 2001, Nature Reviews Molecular Cell Biology.
[135] Barbara Stecca,et al. The Gli code: an information nexus regulating cell fate, stemness and cancer. , 2007, Trends in cell biology.
[136] Allen Li,et al. Induction of sonic hedgehog mediators by transforming growth factor-beta: Smad3-dependent activation of Gli2 and Gli1 expression in vitro and in vivo. , 2007, Cancer research.
[137] Geng-yin Zhou,et al. Interference of Frizzled 1 (FZD1) reverses multidrug resistance in breast cancer cells through the Wnt/β-catenin pathway. , 2012, Cancer letters.
[138] I. Palmeirim,et al. Comprehensive analysis of fibroblast growth factor receptor expression patterns during chick forelimb development. , 2010, The International journal of developmental biology.
[139] W. Bushman. Hedgehog Signaling in Development and Cancer , 2007 .
[140] Johanna Andrae,et al. Role of platelet-derived growth factors in physiology and medicine. , 2008, Genes & development.
[141] David Cunningham,et al. Insulin-like growth factor 1 receptor targeted therapeutics: novel compounds and novel treatment strategies for cancer medicine. , 2009, Recent patents on anti-cancer drug discovery.
[142] M. Datta,et al. Inhibition of prostate cancer proliferation by interference with SONIC HEDGEHOG-GLI1 signaling. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[143] Andhra Pradesh,et al. NANOPARTICLES AS DRUG DELIVERY SYSTEMS , 2012 .
[144] Jia Zhou,et al. Development of targeting lonidamine liposomes that circumvent drug-resistant cancer by acting on mitochondrial signaling pathways. , 2013, Biomaterials.
[145] C. Weston,et al. The JNK signal transduction pathway. , 2007, Current opinion in genetics & development.
[146] A. Harris,et al. New developments in angiogenesis: a major mechanism for tumor growth and target for therapy. , 1998, The cancer journal from Scientific American.
[147] B. O’Malley,et al. Nuclear receptor coregulators in cancer biology. , 2009, Cancer research.
[148] G. Christofori,et al. Placental Growth Factor-1 Attenuates Vascular Endothelial Growth Factor-A–Dependent Tumor Angiogenesis during β Cell Carcinogenesis , 2007 .
[149] M. Nguyen,et al. Estrogen induces lung metastasis through a host compartment-specific response. , 2006, Cancer research.
[150] M. Knowles,et al. Altered splicing of FGFR1 is associated with high tumor grade and stage and leads to increased sensitivity to FGF1 in bladder cancer. , 2010, The American journal of pathology.
[151] M. Knowles,et al. A Decade of FGF Receptor Research in Bladder Cancer: Past, Present, and Future Challenges , 2012, Advances in urology.
[152] Mark B. Carter,et al. The Targeted Delivery of Multicomponent Cargos to Cancer Cells via Nanoporous Particle-Supported Lipid Bilayers , 2011, Nature materials.
[153] P. Polakis. The many ways of Wnt in cancer. , 2007, Current opinion in genetics & development.
[154] M. Katoh. WNT signaling in stem cell biology and regenerative medicine. , 2008, Current drug targets.
[155] R. Manavalan,et al. Poly(D,L-lactic-co-glycolic acid) nanoencapsulation reduces Erlotinib-induced subacute toxicity in rat. , 2009, Journal of biomedical nanotechnology.
[156] Dean Y. Li,et al. Blocking Fibroblast Growth Factor Receptor Signaling Inhibits Tumor Growth, Lymphangiogenesis, and Metastasis , 2012, PloS one.
[157] P. Kuo,et al. Epithelial-mesenchymal transition, the tumor microenvironment, and metastatic behavior of epithelial malignancies. , 2012, International journal of biochemistry and molecular biology.
[158] Yan Liu,et al. Cell and molecular mechanisms of insulin-induced angiogenesis , 2008, Journal of cellular and molecular medicine.
[159] Chiang-Ching Huang,et al. Identification of estrogen-responsive genes involved in breast cancer metastases to the bone , 2007, Clinical & Experimental Metastasis.
[160] Zdenka Kuncic,et al. Nanoparticles in cancer imaging and therapy , 2012 .
[161] P. Brown,et al. Transcriptional Program Induced by Wnt Protein in Human Fibroblasts Suggests Mechanisms for Cell Cooperativity in Defining Tissue Microenvironments , 2007, PloS one.
[162] G. Dontu,et al. Hedgehog signaling and Bmi-1 regulate self-renewal of normal and malignant human mammary stem cells. , 2006, Cancer research.
[163] Ji-Xin Shi,et al. Growth Factors from Tumor Microenvironment Possibly Promote the Proliferation of Glioblastoma-Derived Stem-like Cells in Vitro , 2012, Pathology & Oncology Research.
[164] M. von Knebel Doeberitz,et al. Wnt/β‐catenin‐pathway as a molecular target for future anti‐cancer therapeutics , 2005 .
[165] Z. Duan,et al. Development of EGFR-targeted polymer blend nanocarriers for combination paclitaxel/lonidamine delivery to treat multi-drug resistance in human breast and ovarian tumor cells. , 2011, Molecular pharmaceutics.
[166] John Kuriyan,et al. Structural analysis of the catalytically inactive kinase domain of the human EGF receptor 3 , 2009, Proceedings of the National Academy of Sciences.
[167] A. Naderi,et al. A feedback loop between androgen receptor and ERK signaling in estrogen receptor-negative breast cancer. , 2011, Neoplasia.
[168] K. Makino,et al. HER-2/neu promotes androgen-independent survival and growth of prostate cancer cells through the Akt pathway. , 2000, Cancer research.
[169] K. Alitalo,et al. Expression of the fms-like tyrosine kinase 4 gene becomes restricted to lymphatic endothelium during development. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[170] P. Lollini,et al. Efficacy of and resistance to anti-IGF-1R therapies in Ewing's sarcoma is dependent on insulin receptor signaling , 2011, Oncogene.
[171] Wing-Kai Chan,et al. Targeting Neuropilin 1 as an Antitumor Strategy in Lung Cancer , 2007, Clinical Cancer Research.
[172] L. Ellis,et al. Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[173] N. Evans,et al. The Wnt Signaling Receptor Lrp5 Is Required for Mammary Ductal Stem Cell Activity and Wnt1-induced Tumorigenesis* , 2006, Journal of Biological Chemistry.
[174] Miqin Zhang,et al. pH-Sensitive siRNA nanovector for targeted gene silencing and cytotoxic effect in cancer cells. , 2010, Molecular pharmaceutics.
[175] F. Peruzzi,et al. MINI REVIEW THE IGF-1 RECEPTOR IN CANCER BIOLOGY , 2003 .
[176] M. Giacca,et al. Further Pharmacological and Genetic Evidence for the Efficacy of PlGF Inhibition in Cancer and Eye Disease , 2010, Cell.
[177] T. Golde,et al. Notch signals in the endothelium and cancer "stem-like" cells: opportunities for cancer therapy , 2012, Vascular cell.
[178] F. Radtke,et al. Notch and cancer: a double-edged sword , 2007, Cellular and Molecular Life Sciences.
[179] Michael Kahn,et al. Targeting Wnt Signaling: Can We Safely Eradicate Cancer Stem Cells? , 2010, Clinical Cancer Research.
[180] R. Loberg,et al. Enhanced Glycogen Synthase Kinase-3β Activity Mediates Hypoxia-induced Apoptosis of Vascular Smooth Muscle Cells and Is Prevented by Glucose Transport and Metabolism* , 2002, The Journal of Biological Chemistry.
[181] M. Katoh,et al. WNT Signaling Pathway and Stem Cell Signaling Network , 2007, Clinical Cancer Research.
[182] Yutaka Shimada,et al. Widespread requirement for Hedgehog ligand stimulation in growth of digestive tract tumours , 2003, Nature.
[183] J. Hancock. PA promoted to manager , 2007, Nature Cell Biology.
[184] R. Clarke,et al. Breast cancer stem cells: something out of notching? , 2010, Cancer research.
[185] S. Izraeli,et al. Molecular Pathways Regulating Pro-migratory Effects of Hedgehog Signaling* , 2006, Journal of Biological Chemistry.
[186] Yingqun Wang,et al. Wnt/Planar cell polarity signaling: A new paradigm for cancer therapy , 2009, Molecular Cancer Therapeutics.
[187] Ravi S Kane,et al. Regulation of stem cell signaling by nanoparticle-mediated intracellular protein delivery. , 2011, Biomaterials.
[188] M. Rubini,et al. Simian virus 40 large tumor antigen is unable to transform mouse embryonic fibroblasts lacking type 1 insulin-like growth factor receptor. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[189] E. Kremmer,et al. Neoplastic transformation by Notch is independent of transcriptional activation by RBP-J signalling , 2000, Oncogene.
[190] V. Speirs,et al. Reduced expression of oestrogen receptor β in invasive breast cancer and its re‐expression using DNA methyl transferase inhibitors in a cell line model , 2003, The Journal of pathology.
[191] J. Otlewski,et al. FGF1-gold nanoparticle conjugates targeting FGFR efficiently decrease cell viability upon NIR irradiation , 2012, International journal of nanomedicine.
[192] C. Kahn,et al. Characterization of Multiple Signaling Pathways of Insulin in the Regulation of Vascular Endothelial Growth Factor Expression in Vascular Cells and Angiogenesis* , 2003, Journal of Biological Chemistry.
[193] Yihai Cao,et al. Placenta growth factor-1 antagonizes VEGF-induced angiogenesis and tumor growth by the formation of functionally inactive PlGF-1/VEGF heterodimers. , 2002, Cancer Cell.
[194] E. Wilander,et al. Expression and prognostic significance of platelet-derived growth factor and its receptors in epithelial ovarian neoplasms. , 1993, Cancer research.
[195] P. Hwu. Gene therapy: progress and prospects. , 1994, Contemporary urology.
[196] J. McCubrey,et al. Synergy between PI3K/Akt and Raf/MEK/ERK Pathways in IGF-1R Mediated Cell Cycle Progression and Prevention of Apoptosis in Hematopoietic Cells , 2004, Cell cycle.
[197] J. Yoon,et al. Phospholipase D1 drives a positive feedback loop to reinforce the Wnt/beta-catenin/TCF signaling axis. , 2010, Cancer research.
[198] H. Stein,et al. Jagged1-induced Notch signaling drives proliferation of multiple myeloma cells. , 2004, Blood.
[199] Arie Perry,et al. Notch1 and Notch2 Have Opposite Effects on Embryonal Brain Tumor Growth , 2004, Cancer Research.
[200] Xiaohua Huang,et al. Cancer cell imaging and photothermal therapy in the near-infrared region by using gold nanorods. , 2006, Journal of the American Chemical Society.
[201] Christian Fischer,et al. FLT1 and its ligands VEGFB and PlGF: drug targets for anti-angiogenic therapy? , 2008, Nature Reviews Cancer.
[202] F. Frasca,et al. The role of insulin receptors and IGF-I receptors in cancer and other diseases , 2008, Archives of physiology and biochemistry.
[203] J. McCubrey,et al. The phosphatidylinositol 3-kinase/Akt/mTOR signaling network as a therapeutic target in acute myelogenous leukemia patients , 2010, Oncotarget.
[204] Luigi Marchionni,et al. The Notch Target Hes1 Directly Modulates Gli1 Expression and Hedgehog Signaling: A Potential Mechanism of Therapeutic Resistance , 2010, Clinical Cancer Research.
[205] Y. Kuo,et al. Inhibition of human brain malignant glioblastoma cells using carmustine-loaded catanionic solid lipid nanoparticles with surface anti-epithelial growth factor receptor. , 2011, Biomaterials.
[206] X. Shuai,et al. Targeting EGFR-overexpressing tumor cells using Cetuximab-immunomicelles loaded with doxorubicin and superparamagnetic iron oxide. , 2010, European journal of radiology.
[207] W. Ruf,et al. Tissue factor proangiogenic signaling in cancer progression. , 2012, Thrombosis research.
[208] S. Weiss,et al. A Wnt-Axin2-GSK3beta cascade regulates Snail1 activity in breast cancer cells. , 2006, Nature cell biology.
[209] Zhiwei Wang,et al. Down-regulation of platelet-derived growth factor-D inhibits cell growth and angiogenesis through inactivation of notch-1 and nuclear factor-κB signaling , 2007 .
[210] R L Vessella,et al. Advances in Brief Amplification and Overexpression of Androgen Receptor Gene in Hormone-Refractory Prostate Cancer 1 , 2001 .
[211] M. Scott,et al. Patched 1 Regulates Hedgehog Signaling at the Primary Cilium , 2022 .
[212] L. Nicholson,et al. Ras‐MEK‐ERK signaling cascade regulates androgen receptor element‐inducible gene transcription and DNA synthesis in prostate cancer cells , 2007, International journal of cancer.
[213] Cun-Yu Wang,et al. Notch signaling in the regulation of tumor angiogenesis. , 2006, Trends in cell biology.
[214] L. Aiello,et al. Vascular Endothelial Growth Factor Induces Expression of Connective Tissue Growth Factor via KDR, Flt1, and Phosphatidylinositol 3-Kinase-Akt-dependent Pathways in Retinal Vascular Cells* , 2000, The Journal of Biological Chemistry.
[215] T. Giordano,et al. Crosstalk between tumor and endothelial cells promotes tumor angiogenesis by MAPK activation of Notch signaling. , 2005, Cancer cell.
[216] David Hogg,et al. Mutations in SUFU predispose to medulloblastoma , 2002, Nature Genetics.
[217] Xiaohua Huang,et al. Selective laser photo-thermal therapy of epithelial carcinoma using anti-EGFR antibody conjugated gold nanoparticles. , 2006, Cancer letters.
[218] C. Iacobuzio-Donahue,et al. Blockade of hedgehog signaling inhibits pancreatic cancer invasion and metastases: a new paradigm for combination therapy in solid cancers. , 2007, Cancer research.
[219] J. Allalunis-Turner,et al. Notch signaling as a therapeutic target for breast cancer treatment? , 2011, Breast Cancer Research.
[220] Yihai Cao. Positive and Negative Modulation of Angiogenesis by VEGFR1 Ligands , 2009, Science Signaling.
[221] J. Aster,et al. Notch Signaling in Cancer , 2002, Cancer biology & therapy.
[222] J. Hartman,et al. Estrogen receptor β inhibits 17β-estradiol-stimulated proliferation of the breast cancer cell line T47D , 2004 .
[223] P. Medina,et al. Mammalian target of rapamycin: biological function and target for novel anticancer agents. , 2010, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.
[224] Ana M Soto,et al. The stroma as a crucial target in rat mammary gland carcinogenesis , 2004, Journal of Cell Science.
[225] T. Ohtsuka,et al. Oscillations in notch signaling regulate maintenance of neural progenitors , 2008, International Journal of Developmental Neuroscience.
[226] P. Pantazis,et al. Nanoparticle-based delivery of siDCAMKL-1 increases microRNA-144 and inhibits colorectal cancer tumor growth via a Notch-1 dependent mechanism , 2011, Journal of nanobiotechnology.
[227] D. Feldman,et al. The development of androgen-independent prostate cancer , 2001, Nature Reviews Cancer.
[228] Lisa Brannon-Peppas,et al. Active targeting schemes for nanoparticle systems in cancer therapeutics. , 2008, Advanced drug delivery reviews.
[229] W. Hennink,et al. Nanobody-albumin nanoparticles (NANAPs) for the delivery of a multikinase inhibitor 17864 to EGFR overexpressing tumor cells. , 2013, Journal of controlled release : official journal of the Controlled Release Society.
[230] A. Ostman. PDGF receptors-mediators of autocrine tumor growth and regulators of tumor vasculature and stroma. , 2004, Cytokine & growth factor reviews.
[231] T. Beißbarth,et al. β-catenin-independent WNT signaling in basal-like breast cancer and brain metastasis. , 2011, Carcinogenesis.
[232] H. Werner,et al. Differential Regulation of Insulin-like Growth Factor-I (IGF-I) Receptor Gene Expression by IGF-I and Basic Fibroblastic Growth Factor* , 1997, The Journal of Biological Chemistry.
[233] P. Friedl,et al. Collective cell migration in morphogenesis, regeneration and cancer , 2009, Nature Reviews Molecular Cell Biology.
[234] M. Bidet,et al. The Hedgehog Receptor Patched Functions in Multidrug Transport and Chemotherapy Resistance , 2012, Molecular Cancer Research.
[235] A. Belfiore,et al. In IGF-I receptor-deficient leiomyosarcoma cells autocrine IGF-II induces cell invasion and protection from apoptosis via the insulin receptor isoform A , 2002, Oncogene.
[236] M. Knowles,et al. Alternative splicing of fibroblast growth factor receptor 3 produces a secreted isoform that inhibits fibroblast growth factor-induced proliferation and is repressed in urothelial carcinoma cell lines. , 2005, Cancer research.
[237] Raoul Kopelman,et al. Multifunctional nanoparticle platforms for in vivo MRI enhancement and photodynamic therapy of a rat brain cancer , 2005 .
[238] Xiang Du,et al. Crosstalk between tumor cells and microenvironment via Wnt pathway in colorectal cancer dissemination. , 2008, World journal of gastroenterology.
[239] M. Tenhagen,et al. Fibroblast growth factor receptors in breast cancer: expression, downstream effects, and possible drug targets. , 2012, Endocrine-related cancer.
[240] S. Parsons,et al. c-Src and cooperating partners in human cancer. , 2004, Cancer cell.
[241] Y. Omidi,et al. c-Src antisense complexed with PAMAM denderimes decreases of c-Src expression and EGFR-dependent downstream genes in the human HT-29 colon cancer cell line. , 2012, Asian Pacific journal of cancer prevention : APJCP.
[242] A. Hong,et al. The effects of luminescent ruthenium(II) polypyridyl functionalized selenium nanoparticles on bFGF-induced angiogenesis and AKT/ERK signaling. , 2013, Biomaterials.
[243] S. R. Datta,et al. Cellular survival: a play in three Akts. , 1999, Genes & development.
[244] M. Landthaler,et al. High frequency of FGFR3 mutations in adenoid seborrheic keratoses. , 2006, The Journal of investigative dermatology.
[245] FlorenceSchaffner,et al. Tissue Factor and PAR2 Signaling in the Tumor Microenvironment , 2009 .
[246] Michael Dean,et al. Mutations of the Human Homolog of Drosophila patched in the Nevoid Basal Cell Carcinoma Syndrome , 1996, Cell.
[247] Melissa H Wong,et al. Tumor microenvironment complexity: emerging roles in cancer therapy. , 2012, Cancer research.
[248] J. Ambati,et al. Alternatively spliced vascular endothelial growth factor receptor-2 is an essential endogenous inhibitor of lymphatic vessel growth , 2009 .
[249] M. Washington,et al. Mice expressing activated PI3K rapidly develop advanced colon cancer. , 2012, Cancer research.
[250] M. Wolter,et al. Missense mutations in SMOH in sporadic basal cell carcinomas of the skin and primitive neuroectodermal tumors of the central nervous system. , 1998, Cancer research.
[251] Robert Geisler,et al. Silberblick/Wnt11 mediates convergent extension movements during zebrafish gastrulation , 2000, Nature.
[252] J. Frystyk. Free insulin-like growth factors -- measurements and relationships to growth hormone secretion and glucose homeostasis. , 2004, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.
[253] Carlos S. Moreno,et al. MTA3, a Mi-2/NuRD Complex Subunit, Regulates an Invasive Growth Pathway in Breast Cancer , 2003, Cell.
[254] D. A. Foster. Phosphatidic acid signaling to mTOR: signals for the survival of human cancer cells. , 2009, Biochimica et biophysica acta.
[255] P. Kabos,et al. Blocking HES1 Expression Initiates GABAergic Differentiation and Induces the Expression of p21CIP1/WAF1 in Human Neural Stem Cells* , 2002, The Journal of Biological Chemistry.
[256] Shiladitya Sengupta,et al. Nanoparticle-mediated targeting of phosphatidylinositol-3-kinase signaling inhibits angiogenesis , 2009, Angiogenesis.
[257] Dieter Niederacher,et al. Germline mutations in breast and ovarian cancer pedigrees establish RAD51C as a human cancer susceptibility gene , 2010, Nature Genetics.
[258] D. Leroith,et al. The role of the IGF system in cancer growth and metastasis: overview and recent insights. , 2007, Endocrine reviews.
[259] N. Turner,et al. Fibroblast growth factor signalling: from development to cancer , 2010, Nature Reviews Cancer.
[260] M. Knowles,et al. Fibroblast growth factor receptor 1 promotes proliferation and survival via activation of the mitogen-activated protein kinase pathway in bladder cancer. , 2009, Cancer research.
[261] Enrique Casado,et al. PI3K/Akt signalling pathway and cancer. , 2004, Cancer treatment reviews.
[262] S. Hanks,et al. Specific cross-talk between epidermal growth factor receptor and integrin alphavbeta5 promotes carcinoma cell invasion and metastasis. , 2009, Cancer research.
[263] M. Bittner,et al. The Wnt5A/Protein Kinase C Pathway Mediates Motility in Melanoma Cells via the Inhibition of Metastasis Suppressors and Initiation of an Epithelial to Mesenchymal Transition* , 2007, Journal of Biological Chemistry.
[264] G. Bu,et al. LRP6 overexpression defines a class of breast cancer subtype and is a target for therapy , 2010, Proceedings of the National Academy of Sciences.
[265] R. Samant,et al. Hedgehog Signaling: Networking to Nurture a Promalignant Tumor Microenvironment , 2011, Molecular Cancer Research.
[266] S. Baker,et al. PTEN and the PI3-kinase pathway in cancer. , 2009, Annual review of pathology.
[267] G. Bepler,et al. Activated Epidermal Growth Factor Receptor–Stat-3 Signaling Promotes Tumor Survival In vivo in Non–Small Cell Lung Cancer , 2005, Clinical Cancer Research.
[268] C. Heldin,et al. Platelet-derived growth factor and its receptors in human glioma tissue: expression of messenger RNA and protein suggests the presence of autocrine and paracrine loops. , 1992, Cancer research.
[269] Sailing He,et al. Photosensitizer encapsulated organically modified silica nanoparticles for direct two-photon photodynamic therapy and in vivo functional imaging. , 2012, Biomaterials.
[270] P. V. Van Veldhuizen,et al. Tumor cell-derived PDGF-B potentiates mouse mesenchymal stem cells-pericytes transition and recruitment through an interaction with NRP-1 , 2010, Molecular Cancer.
[271] D. Hwang,et al. Notch1 counteracts WNT/β-catenin signaling through chromatin modification in colorectal cancer. , 2012, The Journal of clinical investigation.
[272] B. Gallez,et al. Nitric oxide delivery to cancer: why and how? , 2009, European journal of cancer.
[273] N. Kennedy,et al. Role of JNK in Tumor Development , 2003, Cell cycle.
[274] A. Costantino,et al. Insulin Receptor Isoform A, a Newly Recognized, High-Affinity Insulin-Like Growth Factor II Receptor in Fetal and Cancer Cells , 1999, Molecular and Cellular Biology.
[275] M. Kuwano,et al. Molecular Mechanisms of Epidermal Growth Factor Receptor (EGFR) Activation and Response to Gefitinib and Other EGFR-Targeting Drugs , 2006, Clinical Cancer Research.
[276] A. Belfiore. The role of insulin receptor isoforms and hybrid insulin/IGF-I receptors in human cancer. , 2007, Current pharmaceutical design.
[277] S. Vyas,et al. Doxorubicin encapsulated nanocarriers for targeted delivery to estrogen responsive breast cancer. , 2011, Journal of biomedical nanotechnology.
[278] A. Sood,et al. Targeting the Notch Ligand Jagged1 in Both Tumor Cells and Stroma in Ovarian Cancer , 2011, Clinical Cancer Research.
[279] R. Baserga,et al. Failure of the bovine papillomavirus to transform mouse embryo fibroblasts with a targeted disruption of the insulin-like growth factor I receptor genes , 1995, Journal of virology.
[280] R. Cardiff,et al. Deregulation of Stat5 expression and activation causes mammary tumors in transgenic mice , 2004, International journal of cancer.
[281] H. Klocker,et al. Androgen receptor activation in prostatic tumor cell lines by insulin-like growth factor-I, keratinocyte growth factor, and epidermal growth factor. , 1994, Cancer research.
[282] R. Radhakrishnan,et al. ErbB3/HER3 intracellular domain is competent to bind ATP and catalyze autophosphorylation , 2010, Proceedings of the National Academy of Sciences.
[283] J. Pessin,et al. Relationship between alpha subunit ligand occupancy and beta subunit autophosphorylation in insulin/insulin-like growth factor-1 hybrid receptors. , 1993, The Journal of biological chemistry.
[284] Qiong Chen,et al. Magnetic iron oxide nanoparticles carrying PTEN gene to reverse cisplatin-resistance of A549/CDDP cell lines , 2012 .
[285] D. Luo,et al. Biologically active core/shell nanoparticles self-assembled from cholesterol-terminated PEG-TAT for drug delivery across the blood-brain barrier. , 2008, Biomaterials.
[286] Dong Liang,et al. Peptide-conjugated polymeric micellar nanoparticles for Dual SPECT and optical imaging of EphB4 receptors in prostate cancer xenografts. , 2011, Biomaterials.
[287] Noah Craft,et al. A mechanism for hormone-independent prostate cancer through modulation of androgen receptor signaling by the HER-2/neu tyrosine kinase , 1999, Nature Medicine.
[288] Bo Mu,et al. The pigment epithelial-derived factor gene loaded in PLGA nanoparticles for therapy of colon carcinoma. , 2010, Oncology reports.
[289] J. M. Marchetti,et al. Photobiological and Ultrastructural Studies of Nanoparticles of Poly(lactic-co-glycolic acid)-Containing Bacteriochlorophyll-a as a Photosensitizer Useful for PDT Treatment , 2005, Drug delivery.
[290] M. Hiraoka,et al. The Akt/mTOR Pathway Assures the Synthesis of HIF-1α Protein in a Glucose- and Reoxygenation-dependent Manner in Irradiated Tumors* , 2009, Journal of Biological Chemistry.
[291] J. Shih,et al. Xwnt-5A: a maternal Wnt that affects morphogenetic movements after overexpression in embryos of Xenopus laevis. , 1993, Development.
[292] Tian-Li Wang,et al. Jagged1 Expression Regulated by Notch3 and Wnt/β-catenin Signaling Pathways in Ovarian Cancer , 2010, Oncotarget.
[293] D. Olson,et al. Antisense wnt-5a mimics wnt-1-mediated C57MG mammary epithelial cell transformation. , 1998, Experimental cell research.
[294] José M. Morachis,et al. Triggered Rapid Degradation of Nanoparticles for Gene Delivery , 2012, Journal of drug delivery.
[295] François Guillemin,et al. Nanoparticles as vehicles for delivery of photodynamic therapy agents. , 2008, Trends in biotechnology.
[296] Jong-Suk Kim,et al. Inhibition of VEGF blocks TGF-β1 production through a PI3K/Akt signalling pathway , 2008, European Respiratory Journal.
[297] C. Stewart,et al. Growth, differentiation, and survival: multiple physiological functions for insulin-like growth factors. , 1996, Physiological reviews.
[298] M. Knowles,et al. FGFR1-Induced Epithelial to Mesenchymal Transition through MAPK/PLCγ/COX-2-Mediated Mechanisms , 2012, PloS one.
[299] F. Uckun,et al. Therapeutic nanoparticle constructs of a JAK3 tyrosine kinase inhibitor against human B-lineage ALL cells , 2010, Arzneimittelforschung.
[300] H. Masoudi,et al. Phosphorylated insulin-like growth factor-i/insulin receptor is present in all breast cancer subtypes and is related to poor survival. , 2008, Cancer research.
[301] Randall T Moon,et al. Wnt and calcium signaling: beta-catenin-independent pathways. , 2005, Cell calcium.
[302] Yutaka Matsuda,et al. Autocrine WNT signaling contributes to breast cancer cell proliferation via the canonical WNT pathway and EGFR transactivation , 2007, Breast Cancer Research.
[303] H. Scher,et al. Collocation of androgen receptor gene mutations in prostate cancer. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.
[304] J. Iwasaki,et al. Anti-angiogenic therapy against gastrointestinal tract cancers. , 2009, Japanese journal of clinical oncology.
[305] D. McDonnell,et al. Coregulators in nuclear estrogen receptor action: from concept to therapeutic targeting. , 2005, Molecular interventions.
[306] Fahima Dilnawaz,et al. Targeted epidermal growth factor receptor nanoparticle bioconjugates for breast cancer therapy. , 2009, Biomaterials.
[307] M. E. Kenney,et al. Addressing brain tumors with targeted gold nanoparticles: a new gold standard for hydrophobic drug delivery? , 2011, Small.
[308] T. Golde,et al. Rational targeting of Notch signaling in cancer , 2008, Oncogene.
[309] M. Guarino. Src signaling in cancer invasion , 2010, Journal of cellular physiology.
[310] J. Richie,et al. Targeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivo. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[311] R. Gurny,et al. Hypericin-loaded nanoparticles for the photodynamic treatment of ovarian cancer. , 2006, International journal of pharmaceutics.
[312] H. Moses,et al. Stromal fibroblasts in cancer initiation and progression , 2004, Nature.
[313] D. Santini,et al. p66Shc/Notch‐3 Interplay Controls Self‐Renewal and Hypoxia Survival in Human Stem/Progenitor Cells of the Mammary Gland Expanded In Vitro as Mammospheres , 2007, Stem cells.
[314] R. Mumper,et al. In vitro and in vivo assessment of targeting lipid-based nanoparticles to the epidermal growth factor-receptor (EGFR) using a novel Heptameric ZEGFR domain. , 2012, Journal of controlled release : official journal of the Controlled Release Society.
[315] Lin Mei,et al. Cholic acid-functionalized nanoparticles of star-shaped PLGA-vitamin E TPGS copolymer for docetaxel delivery to cervical cancer. , 2013, Biomaterials.
[316] N. López-Bigas,et al. Jagged1 is the pathological link between Wnt and Notch pathways in colorectal cancer , 2009, Proceedings of the National Academy of Sciences.
[317] S. Chandarlapaty,et al. PI3K inhibition results in enhanced HER signaling and acquired ERK dependency in HER2-overexpressing breast cancer , 2011, Oncogene.
[318] C. Nguyen,et al. Differential expression assay of chromosome arm 8p genes identifies Frizzled-related (FRP1/FRZB) and Fibroblast Growth Factor Receptor 1 (FGFR1) as candidate breast cancer genes , 1999, Oncogene.
[319] A. Ciucci,et al. Increased melanoma growth and metastasis spreading in mice overexpressing placenta growth factor. , 2006, The American journal of pathology.
[320] Yiling Lu,et al. Src Family Protein-tyrosine Kinases Alter the Function of PTEN to Regulate Phosphatidylinositol 3-Kinase/AKT Cascades* , 2003, Journal of Biological Chemistry.
[321] T. Golde,et al. Targeting Notch to Target Cancer Stem Cells , 2010, Clinical Cancer Research.
[322] J. Romashkova,et al. NF-kappaB is a target of AKT in anti-apoptotic PDGF signalling. , 1999, Nature.
[323] Tara Karnezis,et al. VEGF-D promotes tumor metastasis by regulating prostaglandins produced by the collecting lymphatic endothelium. , 2012, Cancer cell.
[324] S. Fuqua,et al. Cytokine receptor CXCR4 mediates estrogen-independent tumorigenesis, metastasis, and resistance to endocrine therapy in human breast cancer. , 2011, Cancer research.
[325] M. Stampfer,et al. Prediagnostic body-mass index, plasma C-peptide concentration, and prostate cancer-specific mortality in men with prostate cancer: a long-term survival analysis. , 2008, The Lancet. Oncology.
[326] R. Nicholson,et al. Inhibition of insulin receptor isoform-A signalling restores sensitivity to gefitinib in previously de novo resistant colon cancer cells , 2006, British Journal of Cancer.
[327] J. Hartman,et al. Estrogen receptor beta inhibits 17beta-estradiol-stimulated proliferation of the breast cancer cell line T47D. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[328] S. Aaronson,et al. An autocrine mechanism for constitutive Wnt pathway activation in human cancer cells. , 2004, Cancer cell.
[329] A. Cuschieri,et al. Hybrid gold-iron oxide nanoparticles as a multifunctional platform for biomedical application , 2012, Journal of Nanobiotechnology.
[330] S. Wise. Nanocarriers as an emerging platform for cancer therapy , 2007 .
[331] Ira Pastan,et al. Immunotoxin therapy of cancer. , 1993, Nature reviews. Cancer.